Alexion Pharmaceuticals, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alexion Pharmaceuticals with three other
companies in this sector in the United States:
H. Lundbeck A/S
sales of $2.32 billion
Dr.Reddy's Laboratories Ltd
of which 83%
was Generics), and
of which 68%
was Specialty Brands).
During the year ended December of 2016, sales at
Alexion Pharmaceuticals were $3.08 billion.
increase of 18.4%
versus 2015, when the company's sales were $2.60 billion.
This was the fifth consecutive year of sales increases at Alexion Pharmaceuticals
(and since 2011, sales have increased a total of 294%).